HYLASE Wound (ECR Pharmaceuticals Co., Inc.)
Welcome to the PulseAid listing for the HYLASE Wound drug offered from ECR Pharmaceuticals Co., Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ECR Pharmaceuticals Co., Inc. |
| NON-PROPRIETARY NAME: | Sodium Hyaluronate |
| SUBSTANCE NAME: | HYALURONATE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2012-01-06 |
| END MARKETING DATE: | 0000-00-00 |
HYLASE Wound HUMAN PRESCRIPTION DRUG Details:
| Item Description | HYLASE Wound from ECR Pharmaceuticals Co., Inc. |
| LABELER NAME: | ECR Pharmaceuticals Co., Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(g/100g) |
| START MARKETING DATE: | 2012-01-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0095-0073_49a31634-a2f7-46fa-ba93-fb2e5d99c0e4 |
| PRODUCT NDC: | 0095-0073 |
| APPLICATION NUMBER: | |
Other HYALURONATE SODIUM Pharmaceutical Manufacturers / Labelers:
